BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 12, 2016
View Archived Issues
Phase I/II results for novel maternal trivalent GBS vaccine
Read More
Boehringer Ingelheim enrolls first patient in LUME-Meso study of nintedanib
Read More
Abide Therapeutics begins enrollment and dosing in ABX-1431 study
Read More
Novel pGX2303 vaccine provides full protection against RSV in animal model
Read More
ONO-954 compared to latanoprost in glaucoma/ocular hypertension trial
Read More
Shionogi updates progress of fourth quarter of fiscal 2015
Read More
EvOx Therapeutics raises seed funding for the development of novel exosome therapy technology
Read More
Takeda reports highlights of fourth quarter of fiscal 2015
Read More
Johns Hopkins University discloses PSMA imaging agents
Read More
Merck & Co. announces JAK inhibitors
Read More
Incyte patents FGFR-4 inhibitors
Read More
Bristol-Myers Squibb introduces PI3Kdelta inhibitors
Read More
Takeda Pharmaceutical present RBP4-lowering agents
Read More
Ono Pharmaceutical introduces voltage-gated channel activators
Read More
European Commission approves CSL Behring's Idelvion
Read More
FDA awards orphan drug designation for selumetinib as adjuvant treatment of DTC
Read More
Phase I/II results show activity of IMMU-130 in pretreated metastatic colorectal cancer
Read More
Biomarker discoveries from the Annual Meeting of the American Academy of Neurology
Read More
CIADM begins advanced development of anthrax vaccine
Read More
Boehringer Ingelheim, LDC and Max Planck sign agreement to develop schizophrenia treatment
Read More
Jazz Pharmaceuticals completes Alize Pharma II acquisition
Read More
European Commission approves BMS and AbbVie's elotuzumab
Read More
Santen to withdraw DE-109 MAA with plans to resubmit
Read More
Stellar Biotechnologies and Neovacs join to create Neostell
Read More